resiquimod has been researched along with glycolipids in 1 studies
Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (glycolipids) | Trials (glycolipids) | Recent Studies (post-2010) (glycolipids) |
---|---|---|---|---|---|
465 | 14 | 318 | 19,062 | 170 | 5,050 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christensen, D; Lattmann, E; Pedersen, GK; Perrie, Y; Roces, CB; Wilkinson, A | 1 |
1 other study(ies) available for resiquimod and glycolipids
Article | Year |
---|---|
Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.
Topics: Adjuvants, Immunologic; Animals; Female; Glycolipids; Imidazoles; Lipids; Liposomes; Mice, Inbred BALB C; Quaternary Ammonium Compounds; Toll-Like Receptor 7; Vaccines | 2018 |